Clinical Trials in Tennessee
Tennessee is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Tennessee and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 332 actively recruiting studies with Tennessee sites out of 332 registered in total. The busiest research areas in Tennessee are Solid Tumor, Breast Cancer, Acute Myeloid Leukemia. Leading sponsors running trials in the state include Vanderbilt University Medical Center, Merck Sharp & Dohme LLC, National Cancer Institute (NCI). By stage, Tennessee trials break down as Phase 1 (80), Phase 2 (113), Phase 3 (92), Phase 4 (14).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.